AGP Picks
View all

Technology Journal of Ohio: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Journal of Ohio.

Press releases published on August 17, 2026

Tilray Medical Accelerates the Commercial Expansion of Tilray Medical-Branded Cannabis Medicines in the UK with First Direct-to-Patient Launch Through Lyphe Clinic and Lyphe Dispensary
Adial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update
Kamada Declares Cash Dividend of $0.17 Per Share; The Company Reported Record-High Revenue and Profitability for First Six Months of 2026
Questor Engages Financial Advisor and Provides Progress Update on Strategy Refresh
Fulcrum Therapeutics and Slate Medicines Announce Merger Agreement to Advance Next-Generation Migraine Therapies
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET
EyePoint Announces Topline Data from LUGANO, the First of Two Pivotal Phase 3 Clinical Trials for DURAVYU™ 2.7mg in Wet AMD
Enovix Announces CEO Transition and Search
Can-Fite: Namodenoson Enhances the Anti-Cancer Effect of Chemotherapy in Pancreatic Cancer
Blue Ops, a Red Cat Company, and Havoc Partner to Develop Open-Architecture Autonomous Maritime Defense Systems
Evolution Metals & Technologies Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Somantra AI, an Enterprise-Grade AEO GEO and AI Search Visibility Platform, Publishes "Content Graveyard" Analysis: 57% of Domains Cited in ChatGPT and Google Are Never Cited Again
argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis
Instaleap baut seine Präsenz in Europa durch eine strategische Partnerschaft mit SPAR Slowenien aus
Instaleap renforce sa présence en Europe grâce à un partenariat stratégique avec SPAR Slovénie
Mesoblast Achieves Major Milestone Completing Patient Treatment in Pivotal Phase 3 Trial for Chronic Low Back Pain
HUTCHMED Announces ORPATHYS® Plus TAGRISSO® Demonstrated Statistically Significant and Clinically Meaningful Improvements in Progression-Free and Overall Survival in MET-Driven EGFR-Mutated Lung Cancer After Progression on TAGRISSO®

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Technology Journal of Ohio

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.